Asia Pacific Wearable Injectors Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (On-Body Injectors, Off-Body Injectors); Application (Diabetes, Oncology, Cardiovascular Disease, Autoimmune Disease, Other Applications); End User (Hospitals and Clinics, Homecare Setting, Other End User), and, Country

No. of Pages: 117    |    Report Code: TIPRE00013299    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Wearable Injectors Market

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Asia Pacific Wearable Injectors Market – By Type

1.3.2        Asia Pacific Wearable Injectors Market – By Application

1.3.3        Asia Pacific Wearable Injectors Market – By End User

1.3.4        Asia Pacific Wearable Injectors Market – By Country

2.          Asia Pacific Wearable Injectors Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Asia Pacific Wearable Injectors Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        4.2.1 Asia Pacific Wearable Injectors Market - Asia Pacific PEST Analysis

4.3        Expert Opinion                                                                       

5.          Asia Pacific Wearable Injectors Market - Key Market Dynamics

5.          Wearable Injectors Market – Industry Dynamics

5.1        Market Drivers

5.1.1        Increasing Chronic Diseases Prevalence

5.1.2        Technological Advancements and Design Development

5.1.3        Conventional Drug Delivery System Limitations

5.2        Market Restraints

5.2.1        Lack of Adoption in Emerging Countries

5.3        Market Opportunities

5.3.1        Increasing Demand for Biologics

5.4        Future Trends

5.4.1        Integration of Wearable Injectors During Early Drug Development

5.5        Impact Analysis

6.          Wearable Injectors Market – Asia Pacific Analysis

6.1        Asia Pacific Wearable Injectors Market Revenue Forecast and Analysis

6.2        Asia Pacific Wearable Injectors Market, By Geography - Forecast and Analysis

6.3        Market Positioning of Key Players

7.          Wearable Injectors Market– By Type

7.1        Overview

7.2        Wearable Injectors Market Share, by Type, 2019 and 2027 (%)

7.4        On-body Injectors

7.4.1        Overview

7.4.2        On-body Injectors: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

7.5        Off-body Injectors

7.5.1        Overview

7.5.2        Off-body Injectors: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

8.          Wearable Injectors Market– By Application

8.1        Overview

8.2        Wearable Injectors Market Share, by Application, 2019 and 2027 (%)

8.4        Oncology

8.4.1        Overview

8.4.2        Oncology: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

8.5        Diabetes

8.5.1        Overview

8.5.2        Diabetes: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

8.6        Autoimmune Disease

8.6.1        Overview

8.6.2        Autoimmune Disease: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

8.7        Cardiovascular Disease

8.7.1        Overview

8.7.2        Cardiovascular Disease: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

8.8        Other Applications

8.8.1        Overview

8.8.2        Other Applications: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

9.          Wearable Injectors Market– By End User

9.1        Overview                                                                       

9.2        Wearable Injectors Market Share, by End user, 2019 and 2027 (%)

9.4        Homecare Setting

9.4.1        Overview

9.4.2        Homecare Setting: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

9.5        Hospitals and Clinics

9.5.1        Overview

9.5.2        Hospitals and Clinics: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

9.6        Other End Users

9.6.1        Overview

9.6.2        Other End Users: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)

10.       Wearable Injectors Market – Geographic Analysis

10.3     Asia Pacific: Wearable Injectors Market

10.3.1     Overview

10.3.2     Asia Pacific: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)

10.3.3     Asia Pacific Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.4     Asia Pacific Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.3.5     Asia Pacific Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3.6     Asia Pacific: Wearable Injectors Market, by Country, 2019 & 2027 (%)

10.3.7     China: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.7.1       China: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.7.2       China Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.7.3       China Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.3.7.4       China Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3.8     Japan: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.8.1       Japan: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.8.2       Japan Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.8.3       Japan Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.3.8.4       Japan Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3.9     India: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.9.1       India: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.9.2       India Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.9.3       India Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.3.9.4       India Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3.10   South Korea: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.1    South Korea: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.2    South Korea Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.10.3    South Korea Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.3.10.4    South Korea Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3.11   Australia: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.11.1    Australia: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.3.11.2    Australia Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.11.3    Australia Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.3.11.4    Australia Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.       Impact Of COVID-19 Pandemic on Asia Pacific Wearable Injectors Market

11.3     Asia-Pacific: Impact Assessment of COVID-19 Pandemic                                                                       

12.       Wearable Injectors Market –Industry Landscape

12.1     Overview

12.2     Growth Strategies Done by the Companies in the Market, (%)

12.3     Organic Developments

12.3.1     Overview

12.4     Inorganic Developments

12.4.1     Overview

13.       Company Profiles

13.1     BD

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2     CeQur SA

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3     Debiotech S.A.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4     E3D Elcam Drug Delivery Devices

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5     Gerresheimer AG

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6     Tandem Diabetes Care Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7     West Pharmaceutical Services, Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8     Ypsomed AG

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9     Medtronic

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Amgen, Inc.

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.       Appendix         

14.1     About the Insight Partners

14.2     Glossary of Terms


LIST OF TABLES

Table 1.            Asia Pacific Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 2.            Asia Pacific Wearable Injectors Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 3.            Asia Pacific Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 4.            China Wearable Injectors Market, by Type – Revenue and Forecast to 2027(USD Million)

Table 5.            China Wearable Injectors Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 6.            China Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7.            Japan Wearable Injectors Market, by Type – Revenue and Forecast to 2027(USD Million)

Table 8.            Japan Wearable Injectors Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.            Japan Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 10.         India Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11.         India Wearable Injectors Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 12.         India Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13.         South Korea Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14.         South Korea Wearable Injectors Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.         South Korea Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16.         Australia Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 17.         Australia Wearable Injectors Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 18.         Australia Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 19.         List of Abbreviation

 


LIST OF FIGURES

Figure 1.          Asia Pacific Wearable Injectors Market Segmentation

Figure 2.          Asia Pacific Wearable Injectors Market Overview

Figure 3.          Off-body injectors Segment Held Largest Share of Product Segment in Wearable Injectors Market

Figure 4.          China Is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.          Asia Pacific Wearable Injectors Market- Leading Country Markets (US$ Mn)

Figure 6.          Asia Pacific Wearable Injectors Market - Asia Pacific PEST Analysis

Figure 7.          Asia Pacific Wearable Injectors Market Impact Analysis of Drivers and Restraints

Figure 8.          Asia Pacific Wearable Injectors Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.          Asia Pacific Wearable Injectors Market Revenue Share, by Type (2019 and 2027)

Figure 10.        Oral Drug Delivery: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Off-body injectors: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Topical Drug Delivery: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Ocular Drug Delivery: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Pulmonary Drug Delivery: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Nasal Drug Delivery: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Transmucosal Drug Delivery: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Implantable Drug Delivery: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Asia Pacific Wearable Injectors Market Revenue Share, by Application (2019 and 2027)

Figure 19.        Infectious Diseases: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Cancer: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Cardiovascular Diseases: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Diabetes: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Respiratory Diseases: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Central Nervous Systems Disorders: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Autoimmune Diseases: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Other Diseases: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Asia Pacific Wearable Injectors Market Share, by End User, 2019 and 2027 (%)

Figure 28.        Hospitals: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Home Care Settings: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 30.        ASCs/ Clinics: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 31.        Other End Users: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

Figure 32.        Asia Pacific: Wearable Injectors Market, by Key Country – Revenue (2019) (USD Million)

Figure 33.        Asia Pacific Wearable Injectors Market Revenue and Forecast to 2027 (USD Million)

Figure 34.        Asia Pacific: Wearable Injectors Market, by Country, 2019 & 2027 (%)

Figure 35.        China: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 36.        Japan: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 37.        India: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 38.        South Korea: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 39.        Australia: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 40.        Impact of COVID-19 Pandemic in Asia-Pacific Country Markets

 

The List of Companies - Asia Pacific Wearable Injectors Market

  1. BD
  2. CeQur SA
  3. Debiotech S.A
  4. E3D Elcam Drug Delivery Devices
  5. Gerresheimer AG
  6. Tandem Diabetes Care Inc
  7. West Pharmaceutical Services, Inc
  8. Ypsomed AG
  9. Medtronic
  10. Amgen, Inc.